AI assistant
Sending…
Vistin Pharma — Major Shareholding Notification 2021
Oct 29, 2021
3782_mrq_2021-10-29_1d8662b9-b0b2-4c2d-b4af-2ae81279f8d0.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
Vistin Pharma ASA: Disclosure of large shareholding
Vistin Pharma ASA: Disclosure of large shareholding
Pactum AS has on 29 October 2021 sold 3,519,733 shares in Vistin Pharma ASA (the "Issuer"), corresponding to 7.9% of the issued and outstanding shares and votes in the Issuer, at NOK 19.50 per share, to its wholly-owned subsidiary Pactum Vekst AS in connection with an internal reorganization of Pactum AS.
Following the transaction, (i) Pactum AS owns nil shares and votes in the Issuer and (ii) Pactum Vekst AS owns 3,519,733 shares in the Issuer, corresponding to 7.9% of the issued and outstanding shares and votes in the Issuer.
More from Vistin Pharma
Notice of Dividend Amount
2026
May 22
AGM Information
2026
May 20
Report Publication Announcement
2026
May 20
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 28
Remuneration Information
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Annual Report
2026
Apr 28
Annual Report
2026
Apr 28
AGM Information
2026
Apr 28